Cargando…
Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale
PURPOSE: The aim of this study was to explore what methods should be used to determine the minimal important difference (MID) and minimal important change (MIC) in scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43. METHODS: In a...
Autores principales: | Singer, Susanne, Hammerlid, Eva, Tomaszewska, Iwona M., Amdal, Cecilie Delphin, Bjordal, Kristin, Herlofson, Bente Brokstad, Santos, Marcos, Silva, Joaquim Castro, Mehanna, Hisham, Fullerton, Amy, Brannan, Christine, Gonzalez, Loreto Fernandez, Inhestern, Johanna, Pinto, Monica, Arraras, Juan I., Yarom, Noam, Bonomo, Pierluigi, Baumann, Ingo, Galalae, Razvan, Nicolatou-Galitis, Ourania, Kiyota, Naomi, Raber-Durlacher, Judith, Salem, Dina, Fabian, Alexander, Boehm, Andreas, Krejovic-Trivic, Sanja, Chie, Wei-Chu, Taylor, Katherine, Simon, Christian, Licitra, Lisa, Sherman, Allen C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921167/ https://www.ncbi.nlm.nih.gov/pubmed/34272632 http://dx.doi.org/10.1007/s11136-021-02939-6 |
Ejemplares similares
-
Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials
por: Gamper, Eva M., et al.
Publicado: (2021) -
Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients
por: Dirven, Linda, et al.
Publicado: (2021) -
Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer
por: Musoro, Jammbe Z, et al.
Publicado: (2019) -
Estimation of minimally important differences and responder definitions for EORTC QLQ‐MY20 scores in multiple myeloma patients
por: Sully, Kate, et al.
Publicado: (2019) -
Minimal important differences of EORTC QLQ-C30 for metastatic breast cancer patients: Results from a randomized clinical trial
por: Kawahara, Takuya, et al.
Publicado: (2022)